Gupharma is a prominent small molecule Contract Research Organization (CRO) dedicated to supporting biotech and pharmaceutical companies in expediting their drug discovery processes from initial hit to Investigational New Drug (IND) application. Leveraging innovative chemistry, Gupharma provides comprehensive support through high-quality Biology, Drug Metabolism and Pharmacokinetics (DMPK), toxicology, and cGMP scale-up services.
Commitment to Excellence: Renowned for our responsiveness, flexibility, and cost-effectiveness, Gupharma tailors its solutions to meet specific program requirements. Our approach has fostered enduring partnerships within the pharmaceutical sector, with an average client relationship exceeding ten years.
Scientific Capabilities: Our robust scientific team, continuously expanding and evolving, offers fully-integrated services that converge the diverse expertise of multiple disciplines to advance lead candidates toward clinical trials efficiently.